193 related articles for article (PubMed ID: 6448639)
1. Kinetic properties of tripeptide lysyl chloromethyl ketone and lysyl p-nitroanilide derivatives towards trypsin-like serine proteinases.
Collen D; Lijnen HR; De Cock F; Durieux JP; Loffet A
Biochim Biophys Acta; 1980 Sep; 615(1):158-66. PubMed ID: 6448639
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of trypsin-like serine proteinases by tripeptide arginyl and lysyl chloromethylketones.
Lijnen HR; Uytterhoeven M; Collen D
Thromb Res; 1984 Jun; 34(5):431-7. PubMed ID: 6234678
[TBL] [Abstract][Full Text] [Related]
3. Kinetic study of the effect of heparin on the amidase activity of trypsin, plasmin and urokinase.
Yomtova VM; Stambolieva NA; Blagoev BM
Thromb Haemost; 1983 Jun; 49(3):199-203. PubMed ID: 6224310
[TBL] [Abstract][Full Text] [Related]
4. Steady-state kinetics of plasmin- and trypsin-catalysed hydrolysis of a number of tripeptide-p-nitroanilides.
Christensen U; Ipsen HH
Biochim Biophys Acta; 1979 Aug; 569(2):177-83. PubMed ID: 38847
[TBL] [Abstract][Full Text] [Related]
5. Action of crotalase, an enzyme with thrombin-like and kallikrein-like specificities, on tripeptide nitroanilide derivatives.
Simmons G; Bundalian M; Theodor I; Martinoli J; Pirkle H
Thromb Res; 1985 Nov; 40(4):555-61. PubMed ID: 2934864
[TBL] [Abstract][Full Text] [Related]
6. Kinetic studies on the selectivity of a synthetic thrombin-inhibitor using synthetic peptide substrates.
Hijikata A; Okamoto S; Kikumoto R; Tamao Y
Thromb Haemost; 1979 Oct; 42(3):1039-45. PubMed ID: 159513
[TBL] [Abstract][Full Text] [Related]
7. New chromogenic substrates for thrombin with increased specificity.
Kolde HJ; Eberle R; Heber H; Heimburger N
Thromb Haemost; 1986 Oct; 56(2):155-9. PubMed ID: 2949389
[TBL] [Abstract][Full Text] [Related]
8. Evidence for hemiketals as intermediates in the inactivation of serine proteinases with halomethyl ketones.
McMurray JS; Dyckes DF
Biochemistry; 1986 Apr; 25(8):2298-301. PubMed ID: 3518799
[TBL] [Abstract][Full Text] [Related]
9. New fluorogenic substrates for alpha-thrombin, factor Xa, kallikreins, and urokinase.
Morita T; Kato H; Iwanaga S; Takada K; Kimura T
J Biochem; 1977 Nov; 82(5):1495-8. PubMed ID: 591514
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of thrombin by arginine-containing peptide chloromethyl ketones and bis chloromethyl ketone-albumin conjugates.
Odake S; Kam CM; Powers JC
J Enzyme Inhib; 1995; 9(1):17-27. PubMed ID: 8568563
[TBL] [Abstract][Full Text] [Related]
11. Kinetic studies of urokinase-catalysed hydrolysis of 5-oxo-L-prolylglycyl-L-arginine 4-nitroanilide.
Ipsen HH; Christensen U
Biochim Biophys Acta; 1980 Jun; 613(2):476-81. PubMed ID: 6449958
[TBL] [Abstract][Full Text] [Related]
12. Active-site mapping of bovine and human blood coagulation serine proteases using synthetic peptide 4-nitroanilide and thio ester substrates.
Cho K; Tanaka T; Cook RR; Kisiel W; Fujikawa K; Kurachi K; Powers JC
Biochemistry; 1984 Feb; 23(4):644-50. PubMed ID: 6370301
[TBL] [Abstract][Full Text] [Related]
13. Inactivation of trypsin-like enzymes with peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Methods Enzymol; 1981; 80 Pt C():826-42. PubMed ID: 6210829
[No Abstract] [Full Text] [Related]
14. Catalytic properties of serine proteases. 2. Comparison between human urinary kallikrein and human urokinase, bovine beta-trypsin, bovine thrombin, and bovine alpha-chymotrypsin.
Ascenzi P; Menegatti E; Guarneri M; Bortolotti F; Antonini E
Biochemistry; 1982 May; 21(10):2483-90. PubMed ID: 7046788
[TBL] [Abstract][Full Text] [Related]
15. Synthesis of tripeptide chloromethyl ketones and examination of their inhibitory effects on plasmin and plasma kallikrein.
Tsuda Y; Teno N; Okada Y; Wanaka K; Bohgaki M; Hijikata-Okunomiya A; Okamoto U; Naito T; Okamoto S
Chem Pharm Bull (Tokyo); 1989 Nov; 37(11):3108-11. PubMed ID: 2534361
[TBL] [Abstract][Full Text] [Related]
16. Mammalian chymotrypsin-like enzymes. Comparative reactivities of rat mast cell proteases, human and dog skin chymases, and human cathepsin G with peptide 4-nitroanilide substrates and with peptide chloromethyl ketone and sulfonyl fluoride inhibitors.
Powers JC; Tanaka T; Harper JW; Minematsu Y; Barker L; Lincoln D; Crumley KV; Fraki JE; Schechter NM; Lazarus GG
Biochemistry; 1985 Apr; 24(8):2048-58. PubMed ID: 3893542
[TBL] [Abstract][Full Text] [Related]
17. New fluorogenic peptide substrates for plasmin.
Kato H; Adachi N; Ohno Y; Iwanaga S; Takada K; Sakakibara S
J Biochem; 1980 Jul; 88(1):183-90. PubMed ID: 6447693
[TBL] [Abstract][Full Text] [Related]
18. The susceptibility of urokinase to affinity labeling by peptides of arginine chloromethyl ketone.
Kettner C; Shaw E
Biochim Biophys Acta; 1979 Jul; 569(1):31-40. PubMed ID: 465506
[TBL] [Abstract][Full Text] [Related]
19. Studies on the effect of serine protease inhibitors on activated contact factors. Application in amidolytic assays for factor XIIa, plasma kallikrein and factor XIa.
Tans G; Janssen-Claessen T; Rosing J; Griffin JH
Eur J Biochem; 1987 May; 164(3):637-42. PubMed ID: 3552674
[TBL] [Abstract][Full Text] [Related]
20. The irreversible inhibition of urokinase, kidney-cell plasminogen activator, plasmin and beta-trypsin by 1-(N-6-amino-n-hexyl)carbamoylimidazole.
Walker B; Elmore DT
Biochem J; 1984 Jul; 221(1):277-80. PubMed ID: 6235806
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
